Pietro Ferraro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pietro Ferraro has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Alessandro Della Camera
Department of Molecular and Developmental Medicine, Post Graduate School of Public Health, University of Siena, 53100 Siena, Italy
1 shared publication - Alessio Corazza
SAES Getters S.p.A.
1 shared publication - Davide Amodeo
Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy
1 shared publication - Gabriele Cevenini
Department of Medical Biotechnologies, University of Siena, Siena, Italy
1 shared publication - Gabriella Messina
Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy
1 shared publication - Nicola Nante
Post Graduate School of Public Health, University of Siena, 53100 Siena, Italy
1 shared publication
Latest Publications
- Open Access
- 7 April 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (8) , 3873
An Emerging Innovative UV Disinfection Technology (Part II): Virucide Activity on SARS-CoV-2
The coronavirus SARS-CoV-2 pandemic has become a global health burden. Surface sanitation is one of the key points to reduce the risk of transmission both in healthcare and other public spaces. UVC light is already used in hospital and laboratory infection control, and some recent studies have shown its effectiveness on SARS-CoV-2. An innovative UV chip technology, described in Part I of this study, has recently appeared able to overcome the limits of old lamps and is proposed as a valid alternative to LEDs. This study was designed to test the virucidal activity on SARS-CoV-2 of a device based on the new UV chip technology. Via an initial concentration of virus suspension of 107.2 TCID50/mL, the tests revealed a viral charge reduction of more than 99.9% after 3 min; the maximum detectable attenuation value of Log10 = 5.7 was measured at 10 min of UV exposure.
- 7 April 2021
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (8) , 3873
Open AccessAn Emerging Innovative UV Disinfection Technology (Part II): Virucide Activity on SARS-CoV-2
The coronavirus SARS-CoV-2 pandemic has become a global health burden. Surface sanitation is one of the key points to reduce the risk of transmission both in healthcare and other public spaces. UVC light is already used in hospital and laboratory infection control, and some recent studies have shown its effectiveness on SARS-CoV-2. An innovative UV chip technology, described in Part I of this study, has recently appeared able to overcome the limits of old lamps and is proposed as a valid alternative to LEDs. This study was designed to test the virucidal activity on SARS-CoV-2 of a device based on the new UV chip technology. Via an initial concentration of virus suspension of 107.2 TCID50/mL, the tests revealed a viral charge reduction of more than 99.9% after 3 min; the maximum detectable attenuation value of Log10 = 5.7 was measured at 10 min of UV exposure.